| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4/A: McCarthy Sean A., Director
Received 101,793 shares by exercise or conversion ($162K) · Sold 101,793 shares ($462K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 | SCHEDULE 13G |
| 06 Aug 2026 | S-8 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 05 Aug 2026 |
Form 4: Carvajal Alejandra, Chief Legal Officer
Received 100,000 shares as a grant or award · Granted 450,000 Stock Option (Right to Buy) |
| 05 Aug 2026 |
Form 3: Carvajal Alejandra, Chief Legal Officer
No securities owned |
| 03 Aug 2026 | SCHEDULE 13G |
| 30 Jul 2026 |
Form 4: Fuchs Charles S., Director
Granted 118,000 Stock Option (Right to Buy) |
| 30 Jul 2026 |
Form 3: Fuchs Charles S., Director
No securities owned |
| 27 Jul 2026 | SCHEDULE 13G |
| 27 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 22 Jun 2026 |
Form 4: Su Zhen, Director
Granted 59,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Young Matthew P., Director
Granted 59,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Mohindru Mani, Director
Granted 59,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Meyers James R, Director
Granted 59,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Gilbert Halley E, Director
Granted 59,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Ashworth Alan, Director
Granted 59,000 Stock Option (Right to Buy) |
Loading...